Increasing research and development activities in the pharmaceutical and biotechnology industries driving demand for protein purification and isolation technologies.
Rising prevalence of chronic diseases and growing focus on personalized medicine fueling the adoption of protein purification and isolation techniques in drug discovery and development.
Technological advancements and automation in protein purification and isolation processes enhancing efficiency and productivity in research and production.
Industry
Report Coverage | Details |
---|---|
Segments Covered | Product, Technology, Application, End Users |
Regions Covered | • North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA) |
Company Profiled | KGaA, Thermo Fischer Scientific,, GE Healthcare Life Sciences, Qiagen N.V., Sigma-Aldrich Agilent Technologies |
High cost associated with protein purification and isolation equipment and reagents limiting adoption, especially in developing economies.
Complexity and time-consuming nature of protein purification and isolation procedures posing challenges in achieving high throughput and cost-effective production.